KMT9-IN-2
Product Specifications
Target
Epigenetic Reader Domain
Related Pathways
Chromatin/Epigenetic
Bioactivity
KMT9-IN-2 (Compound 7b) is an active form of a KMT9 inhibitor with a dissociation constant (Kd) of 10 nM. This compound is applicable for research in colon cancer.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
